Afterintervention with the macrophage depleting agent Liposome encapsulated clodronate(LEC), the degree of myocardial hypertrophy and fibrosis decreased, and theexpression of TGF-β1, TNF-α1, and IL-1β decreased. The gene discussed is TGFB1; the disease is cardiac hypertrophy.